These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3424884)

  • 1. [Prevention of ischemic heart disease--experiences and conclusions from the Erfurt intervention study].
    Knappe J
    Z Gesamte Inn Med; 1987 Oct; 42(19):536-9. PubMed ID: 3424884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The Roman coronary heart disease prevention program. Final results].
    G Ital Cardiol; 1982; 12(8):541-54. PubMed ID: 7169153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European and American recommendations for coronary heart disease prevention.
    Wood D
    Eur Heart J; 1998 Feb; 19 Suppl A():A12-9. PubMed ID: 9519337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease.
    Vestfold Heartcare Study Group
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):429-37. PubMed ID: 14671465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems in prevention of ischaemic heart disease.
    Geizerová H; Widimský J
    Cor Vasa; 1976; 18(2):119-28. PubMed ID: 947672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the decrease of cardiovascular mortality in Poland associated with the reduction of global cardiovascular risk related to changes in life style?
    Rywik SL; Piotrowski W; Rywik TM; Broda G; Szcześniewska D
    Kardiol Pol; 2003 May; 58(5):344-55; discussion: 355. PubMed ID: 14523482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do risk factors change in men at high risk of coronary heart disease? Observations on the effect of health promotion in primary care.
    Roderick PJ; Brennan PJ; Meade TW
    J Cardiovasc Risk; 1995 Aug; 2(4):353-7. PubMed ID: 8536154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.
    EUROASPIRE II Study Group
    Eur Heart J; 2001 Apr; 22(7):554-72. PubMed ID: 11259143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The German Cardiovascular Prevention Study (GCP): design and methods. GCP Study Group.
    Eur Heart J; 1988 Oct; 9(10):1058-66. PubMed ID: 3061818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of Hong Kong Chinese patients with coronary heart disease.
    Chair SY; Lee SF; Lopez V; Ling EM
    J Clin Nurs; 2007 Jul; 16(7):1278-84. PubMed ID: 17584346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current standard of care in patients affected by coronary heart disease in Italy: the MC'95 study.
    Magnani B; Dal Palù C; Zanchetti A;
    Ital Heart J; 2002 Feb; 3(2):86-95. PubMed ID: 11926017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lifestyle modifications to prevent and control hypertension. 3. Recommendations on alcohol consumption. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Campbell NR; Ashley MJ; Carruthers SG; Lacourcière Y; McKay DW
    CMAJ; 1999 May; 160(9 Suppl):S13-20. PubMed ID: 10333849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of cluster analysis in prevention of coronary heart disease.
    Pereira C; Vogelaere P
    Rev Port Cardiol; 2005 Mar; 24(3):381-94. PubMed ID: 15929622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Coronary heart disease risk factors in Croatia and worldwide: results of the Interheart study].
    Carević V; Rumboldt M; Rumboldt Z;
    Acta Med Croatica; 2007 Jun; 61(3):299-306. PubMed ID: 17629106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Coronary heart diseases--epidemiology 1984].
    Epstein FH
    Z Kardiol; 1984; 73 Suppl 2():135-41. PubMed ID: 6335624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and secondary prevention of ischemic coronary events in Croatia (TASPIC-CRO study).
    Reiner Z; Mihatov S; Milicić D; Bergovec M; Planinc D;
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):646-54. PubMed ID: 16874158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between risk factors and ischaemic heart disease mortality in a representative sample of men aged 45-59 years in Kaunas.
    Misjaviciene IS; Baubiniene AV; Grabauskas VI; Domarkiene SB; Margjaviciene DE; Prochorskas RP; Reklajtiene RA
    Cor Vasa; 1985; 27(4):236-42. PubMed ID: 4053614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part III. Secondary prevention of ischaemic heart disease after discharge].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):964-8. PubMed ID: 11987836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.